Literature DB >> 23433880

Renal tumors with clear cells. A review.

José I López1.   

Abstract

The spectrum of primary renal tumors in which clear cells may appear is revisited in this review. The pathologist's viewpoint of this topic is pertinent because not all the tumors with clear cells are carcinomas and not all renal cell carcinomas with clear cells are clear cell renal cell carcinomas. In fact, some of them are distinct entities according to the new WHO classification. The morphological approach is combined with genetics. Renal cell carcinoma related to von Hippel-Lindau disease is reviewed first because many of the genetic disorders underlying this disease are also present in sporadic, conventional renal cell clear cell carcinomas. Subsequently, conventional renal cell clear cell carcinomas, familial, non von Hippel-Lindau-associated renal cell carcinomas, translocation carcinomas, hereditary papillary renal cell carcinomas, carcinomas associated to tuberous sclerosis and to Birt-Hogg-Dubé syndrome, chromophobe renal cell carcinomas, carcinomas associated with end-stage renal disease, and clear cell tubulopapillary carcinomas are reviewed. Finally, epithelioid angiomyolipoma is also considered in this review.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23433880     DOI: 10.1016/j.prp.2013.01.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  17 in total

1.  Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous.

Authors:  Laura Zaldumbide; Asier Erramuzpe; Rosa Guarch; Jesús M Cortés; José I López
Journal:  Virchows Arch       Date:  2014-11-05       Impact factor: 4.064

2.  Increased Nicotinamide Phosphoribosyltransferase and Cystathionine-β-Synthase in Renal Oncocytomas, Renal Urothelial Carcinoma, and Renal Clear Cell Carcinoma.

Authors:  Rodney E Shackelford; Jehan Abdulsattar; Eric X Wei; James Cotelingam; Domenico Coppola; Guillermo A Herrera
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

3.  Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.

Authors:  Asier Erramuzpe; Jesús M Cortés; José I López
Journal:  Virchows Arch       Date:  2017-08-25       Impact factor: 4.064

Review 4.  A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma.

Authors:  Caroline E Nunes-Xavier; Javier C Angulo; Rafael Pulido; José I López
Journal:  Curr Urol Rep       Date:  2019-01-15       Impact factor: 3.092

Review 5.  Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.

Authors:  José I López; Javier C Angulo
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

Review 6.  Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma.

Authors:  Jun Wang; Rafia S Al-Lamki
Journal:  Biomed Res Int       Date:  2013-11-17       Impact factor: 3.411

7.  Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.

Authors:  Xiancheng Chen; Yang Yang; Weidong Gan; Linfeng Xu; Qing Ye; Hongqian Guo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Synchronous Renal Cell Carcinoma and Gastrointestinal Malignancies.

Authors:  Tamer J Dafashy; Cameron K Ghaffary; Kyle T Keyes; Joseph Sonstein
Journal:  Case Rep Urol       Date:  2016-01-19

9.  Interpretable deep learning uncovers cellular properties in label-free live cell images that are predictive of highly metastatic melanoma.

Authors:  Assaf Zaritsky; Andrew R Jamieson; Erik S Welf; Andres Nevarez; Justin Cillay; Ugur Eskiocak; Brandi L Cantarel; Gaudenz Danuser
Journal:  Cell Syst       Date:  2021-06-01       Impact factor: 11.091

10.  Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein.

Authors:  Giovanni Minervini; Gabriella M Mazzotta; Alessandro Masiero; Elena Sartori; Samantha Corrà; Emilio Potenza; Rodolfo Costa; Silvio C E Tosatto
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.